Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Wilson, Geneva M
Suda, Katie J
Fitzpatrick, Margaret A
Bartle, Brian
Pfeiffer, Christopher D
Jones, Makoto
Rubin, Michael A
Perencevich, Eli
Evans, Martin
and
Evans, Charlesnika T
2021.
Risk Factors Associated With Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Positive Cultures in a Cohort of US Veterans.
Clinical Infectious Diseases,
Vol. 73,
Issue. 8,
p.
1370.
Hovan, Michael R.
Narayanan, Navaneeth
Cedarbaum, Vanessa
Bhowmick, Tanaya
and
Kirn, Thomas J.
2021.
Comparing mortality in patients with carbapenemase-producing carbapenem resistant Enterobacterales and non-carbapenemase-producing carbapenem resistant Enterobacterales bacteremia.
Diagnostic Microbiology and Infectious Disease,
Vol. 101,
Issue. 4,
p.
115505.
Wu, Alice Ying-Jung
Chang, Hsun
Wang, Nai-Yu
Sun, Fang-Ju
and
Liu, Chang-Pan
2022.
Clinical and molecular characteristics and risk factors for patients acquiring carbapenemase-producing and non-carbapenemase-producing carbapenem-nonsusceptible-Enterobacterales bacteremia.
Journal of Microbiology, Immunology and Infection,
Vol. 55,
Issue. 6,
p.
1229.
Jeong, Ihn Sook
and
Song, Ju Yeoun
2022.
Epidemiological Characteristics of Carbapenemase Producing Carbapenem-Resistant Enterobacteriaceae Colonization.
Asian Nursing Research,
Vol. 16,
Issue. 3,
p.
134.
Onorato, Lorenzo
Sarnelli, Bruno
D’Agostino, Federica
Signoriello, Giuseppe
Trama, Ugo
D’Argenzio, Angelo
Montemurro, Maria Vittoria
and
Coppola, Nicola
2022.
Epidemiological, Clinical and Microbiological Characteristics of Patients with Bloodstream Infections Due to Carbapenem-Resistant K. Pneumoniae in Southern Italy: A Multicentre Study.
Antibiotics,
Vol. 11,
Issue. 5,
p.
633.
Kengkla, Kirati
Wongsalap, Yuttana
Chaomuang, Natthaya
Suthipinijtham, Pichaya
Oberdorfer, Peninnah
and
Saokaew, Surasak
2022.
Clinical and economic outcomes attributable to carbapenem-resistant Enterobacterales and delayed appropriate antibiotic therapy in hospitalized patients.
Infection Control & Hospital Epidemiology,
Vol. 43,
Issue. 10,
p.
1349.
Kaye, Keith S.
Naas, Thierry
Pogue, Jason M.
and
Rossolini, Gian Maria
2023.
Cefiderocol, a Siderophore Cephalosporin, as a Treatment Option for Infections Caused by Carbapenem-Resistant Enterobacterales.
Infectious Diseases and Therapy,
Vol. 12,
Issue. 3,
p.
777.
Vock, Isabelle
Ragozzino, Silvio
Urwyler, Pascal
Baumann, Michelle
Capoferri, Gioele
Keller, Peter M.
and
Tschudin-Sutter, Sarah
2024.
Screening sites for detection of carbapenemase-producers– a retrospective cohort study.
Antimicrobial Resistance & Infection Control,
Vol. 13,
Issue. 1,
Saidel-Odes, Lisa
Sagi, Orli
Troib, Shani
Leeman, Hannah
Nativ, Ronit
Schlaeffer-Yosef, Tal
Azulay, Hovav
Nesher, Lior
and
Borer, Abraham
2024.
Risk Factors and Outcomes of Patients Colonized with KPC and NDM Carbapenemase-Producing Enterobacterales.
Antibiotics,
Vol. 13,
Issue. 5,
p.
427.
Alraddadi, Basem
Heaphy, Emily
Alzahrani, Muhannad
Alqadi, Mouad
Qashqari, Moayad
Alhuthali, Mohammed
Al Hroub, Mohammad
Hefni, Lama
Alshukairi, Abeer
Aldabbagh, Yasser
and
Qutub, Mohammed
2024.
Association Between Carbapenem-Resistant Enterobacterales (CRE) Colonization Status at Time of Hospital Admission and the Subsequent Development of CRE Infection and Mortality in High-Risk Patients.
Infection and Drug Resistance,
Vol. Volume 17,
Issue. ,
p.
4655.
Octaria, Rany
Deppen, Stephen
Chan, Allison
Slaughter, James C.
Talley, Pamela
Slayton, Rachel B.
Rebeiro, Peter F.
and
Kainer, Marion A.
2025.
Improving containment and prevention strategies using a patient transfer network representative of patients with multidrug-resistant organisms.
Infection Control & Hospital Epidemiology,
p.
1.